Year |
Citation |
Score |
2020 |
Good D, Challacome B, Cahill D, McNeill S. Beware of snapshot PROM prostate cancer studies without baseline adjustment: Insights from a prospective UK comparison study European Urology Open Science. 19: e1767-e1768. DOI: 10.1016/s2666-1683(20)33785-x |
0.445 |
|
2015 |
Gallagher K, McMorran D, Good D, Stewart G, McNeill S. 516 A matched pair analysis of biochemical recurrence after radical prostatectomy in T2 and T3 prostate cancer with and without positive surgical margins European Urology Supplements. 14: e516-e516a. DOI: 10.1016/S1569-9056(15)60509-7 |
0.38 |
|
2014 |
Robertson JM, Molloy GJ, Bollina PR, Kelly DM, McNeill SA, Forbat L. Exploring the feasibility and acceptability of couple-based psychosexual support following prostate cancer surgery: study protocol for a pilot randomised controlled trial. Trials. 15: 183. PMID 24886676 DOI: 10.1186/1745-6215-15-183 |
0.31 |
|
2014 |
Good DW, Stewart GD, McNeill SA. Establishing an audio recording service for patients with prostate cancer. Bmj (Clinical Research Ed.). 348: g2436. PMID 24699126 DOI: 10.1136/bmj.g2436 |
0.365 |
|
2014 |
McNeill SA, Good DW, Stewart GD, Stolzenburg JU. Five-year oncological outcomes of endoscopic extraperitoneal radical prostatectomy (EERPE) for prostate cancer: results from a medium-volume UK centre. Bju International. 113: 449-57. PMID 23980640 DOI: 10.1111/bju.12260 |
0.338 |
|
2014 |
Good DW, Stewart GD, Zakikhani P, Yuen H, Riddick AC, Bollina PR, O'Donnell M, Stolzenburg JU, McNeill SA. Midterm oncological outcome and clinicopathological characteristics of anterior prostate cancers treated by endoscopic extraperitoneal radical prostatectomy. World Journal of Urology. 32: 393-8. PMID 23760355 DOI: 10.1007/s00345-013-1114-3 |
0.468 |
|
2013 |
Stewart GD, Van Neste L, Delvenne P, Delrée P, Delga A, McNeill SA, O'Donnell M, Clark J, Van Criekinge W, Bigley J, Harrison DJ. Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study. The Journal of Urology. 189: 1110-6. PMID 22999998 DOI: 10.1016/j.juro.2012.08.219 |
0.328 |
|
2011 |
Stewart GD, El-Mokadem I, McLornan ME, Stolzenburg JU, McNeill SA. Functional and oncological outcomes of men under 60 years of age having endoscopic surgery for prostate cancer are optimal following intrafascial endoscopic extraperitoneal radical prostatectomy. The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland. 9: 65-71. PMID 21342669 DOI: 10.1016/j.surge.2010.07.005 |
0.405 |
|
2007 |
Higgins GS, Stewart GD, McNeill SA, McLaren DB. A long and winding road: the role of chemotherapy for hormone-refractory prostate cancer. International Journal of Clinical Practice. 61: 1964-5. PMID 17997800 DOI: 10.1111/j.1742-1241.2007.01550.x |
0.377 |
|
2007 |
Mariappan P, Brown D, McNeill S. 185 INTRAVESICAL PROSTATIC PROTRUSION (IPP) IS BETTER THAN PROSTATE VOLUME (PV) IN PREDICTING THE OUTCOME OF TRIAL WITHOUT CATHETER (TWOC) IN CAUCASIAN MEN PRESENTING WITH ACUTE URINARY RETENTION (AUR) - A PROSPECTIVE CLINICAL STUDY European Urology Supplements. 6: 69. DOI: 10.1016/S1569-9056(07)60184-5 |
0.377 |
|
2006 |
Yang TH, Leung SK, Phipps S, Reuben RL, McNeill SA, Habib FK, Schnieder A, Stevens R. In-vitro dynamic micro-probing and the mechanical properties of human prostate tissues. Technology and Health Care : Official Journal of the European Society For Engineering and Medicine. 14: 281-96. PMID 17065751 |
0.313 |
|
2006 |
Stewart GD, Riddick AC, Bollina PR, McNeill SA. Results of a definitive study are needed to provide guidance on the treatment of patients with screen-detected, 'low-grade' prostate cancer. Bju International. 98: 944-5. PMID 17034595 DOI: 10.1111/j.1464-410X.2006.06540.x |
0.362 |
|
2006 |
van de Riet JE, Benton EC, McNeill SA. Prostatic infarction involving the urinary sphincter, an association with pyoderma gangrenosum. European Urology. 49: 575-7. PMID 16417963 DOI: 10.1016/j.eururo.2005.11.017 |
0.383 |
|
2006 |
Van De Riet JE, Benton EC, McNeill SA. Prostatic infarction involving the urinary sphincter, an association with pyoderma gangrenosum: Part 2 European Urology. 49: 748. DOI: 10.1016/j.eururo.2006.02.009 |
0.378 |
|
2006 |
Leung SKW, McNeill SA. Therapeutic options for benign prostate hyperplasia (BPH) and prostatic Cancer Andrology For the Clinician. 535-550. DOI: 10.1007/3-540-33713-X_91 |
0.495 |
|
2006 |
McNeill SA, Leung SKW. Benign prostatic hyperplasia and prostatic cancer Andrology For the Clinician. 213-216. DOI: 10.1007/3-540-33713-X_48 |
0.437 |
|
2005 |
Phipps S, Yang TH, Habib FK, Reuben RL, McNeill SA. Measurement of tissue mechanical characteristics to distinguish between benign and malignant prostatic disease. Urology. 66: 447-50. PMID 16098374 DOI: 10.1016/j.urology.2005.03.017 |
0.323 |
|
2005 |
Phipps S, Yang TH, Habib FK, Reuben RL, McNeill SA. Measurement of the mechanical characteristics of benign prostatic tissue: a novel method for assessing benign prostatic disease. Urology. 65: 1024-8. PMID 15882757 DOI: 10.1016/j.urology.2004.12.022 |
0.365 |
|
2005 |
Ghani KR, Grigor K, Tulloch DN, Bollina PR, McNeill SA. Trends in reporting Gleason score 1991 to 2001: changes in the pathologist's practice. European Urology. 47: 196-201. PMID 15661414 DOI: 10.1016/j.eururo.2004.07.029 |
0.429 |
|
2005 |
Roehrborn CG, Hargreave TB, McNeill SA, Naadimuthu A, Beffy J. 1635: Prostate Specific Antigen (PSA) and Post Void Residual (PVR) Urine Volume Predict Relapse of Urinary Retention and Need for Surgery in Patients with Benign Prostatic Hyperplasia (BPH) After a First Episode of Acute Urinary Retention (AUR) Journal of Urology. 173: 442-443. DOI: 10.1016/s0022-5347(18)35757-4 |
0.388 |
|
2004 |
Turner K, McNeill SA. MTOPS: conclusions about invasive therapy for BPH should be interpreted with caution. Bju International. 94: 1143. PMID 15541145 DOI: 10.1111/j.1464-410X.2004.05213_2.x |
0.334 |
|
2003 |
Phipps S, Yang THJ, McNeill SA, Habib FK, Reuben RL. The relationship between prostatic tissue morphology and mechanical properties: In vitro studies European Urology, Supplements. 2: LVIII. |
0.318 |
|
2001 |
McNeill SA, Hargreave TB, Geffriaud-Ricouard C, Santoni J, Roehrborn CG. Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin. Urology. 57: 459-65. PMID 11248620 |
0.326 |
|
2000 |
McNeill SA, Hargreave TB. Efficacy of PSA in the detection of carcinoma of the prostate in patients presenting with acute urinary retention. Journal of the Royal College of Surgeons of Edinburgh. 45: 227-30. PMID 11130021 |
0.343 |
|
1999 |
McNeill SA, Thomas J, Hargreave TB. The British Prostate Group Autumn Meeting, 20-21 September 1999, Keble College, Oxford. Prostate Cancer and Prostatic Diseases. 2: 294-299. PMID 12497178 DOI: 10.1038/sj.pcan.4500379 |
0.369 |
|
Show low-probability matches. |